Kimberly-Clark's Q1 Earnings Top Estimates, Organic Sales Down 1.6%
Werte in diesem Artikel
Kimberly-Clark Corporation KMB reported its first-quarter 2025 results, with the top line missing the Zacks Consensus Estimate but the bottom line exceeding the same. However, both metrics declined year over year. Kimberly-Clark’s results highlight the continued execution of its Powering Care strategy, with strong productivity gains and consumer-focused innovation driving competitive advantages. Despite rising global supply-chain costs, the company maintained alignment with its full-year plan, demonstrating operational discipline and strategic resilience. Management also provided updated guidance for 2025, factoring in evolving external conditions.Kimberly-Clark Corporation Price, Consensus and EPS Surprise Kimberly-Clark Corporation price-consensus-eps-surprise-chart | Kimberly-Clark Corporation QuoteTaking a Closer Look at KMB’s Q1 ResultsThe adjusted earnings were $1.93 per share, which beat the Zacks Consensus Estimate of $1.89. However, the bottom line declined 4% year over year due to reduced adjusted operating profit and net income from equity companies. These were somewhat offset by a lower adjusted effective tax rate. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Kimberly-Clark’s sales were $4,840 million, marking a 6% decline from $5,149 million in the same period last year. The figure was down from the Zacks Consensus Estimate of $4,864 million. Unfavorable foreign currency exchange rates negatively impacted sales by roughly 2.4%, as well as a combined 2% sales reduction due to the divestiture of the Personal Protective Equipment (“PPE”) business and the exit from the private label diaper business in the United States.The company’s organic sales declined 1.6%, primarily due to a 1.5% decrease in pricing, while volume and mix remained flat year over year.The adjusted gross margin reached 36.9%, marking a 20-basis point (bps) decrease.Adjusted operating profit fell 6% to $844 million, including a 2.2% unfavorable impact from currency translation.KMB Provides Q1 Insights by SegmentNorth America (“NA”) segment’s net sales reached $2,666 million, marking a 3.9% decline, due to the divestiture of the PPE business and the exit from the private label diaper business in the United States. Organic sales decreased 0.6%, mainly caused by a 0.6% unfavorable pricing impact, as the company focused on targeted investments in the price-pack architecture of its Baby and Child Care portfolio and enhancing value propositions in Professional.NA’s operating profit was $676 million, reflecting a 1.3% increase. This was primarily due to strong productivity savings and optimized marketing, selling, research and general expenses. However, it was partially offset by the impacts of divestitures, business exits and planned investments in the price-value tiers of the portfolio.The International Personal Care (“IPC”) segment’s net sales were $1,383 million, down 8.9%, with organic sales declining 2.8%. This decrease was mainly caused by price investments across markets as the company continued to enhance its value propositions.IPC’s operating profit reached $194 million, marking a 19.8% decrease, which includes an unfavorable currency translation impact of 5%. The decline in operating profit was caused by planned investments in price-value tiers, resulting in negative pricing after cost inflation, partially offset by productivity savings.The International Family Care & Professional (“IFP”) segment reported net sales of $791 million, a 7.7% decline, primarily due to divestitures, business exits and unfavorable currency impacts. Organic sales decreased 2.3%, caused by unfavorable price impacts of 2.6%, reflecting price investments to stay competitive across International Family Care markets.IFP’s operating profit reached $106 million, reflecting a 3.6% decrease, mainly caused by unfavorable currency translation impacts, as favorable costs and strong productivity savings were offset by investments in price-value propositions.Kimberly-Clark’s Financial Health SnapshotThis Zacks Rank #2 (Buy) company ended the quarter with cash and cash equivalents of $563 million, long-term debt of $6,481 million and total stockholders’ equity of $1,224 million.For the three months ended March 31, cash provided by operations was $327 million. Management incurred capital spending of $204 million in the same time frame. The company returned $466 million to its shareholders via dividends and share buybacks.What to Expect From KMB in 2025In line with its long-term growth strategy, Kimberly-Clark expects 2025 organic sales growth to exceed the weighted average growth in the markets and categories it operates. These are currently growing between 1.5% and 2%, slightly below the 2% anticipated at the start of the year.For 2025, the company’s net sales are expected to reflect a negative impact of approximately 200 bps from currency translation, an improvement from the previous forecast of 300 bps. Additionally, the divestiture of its PPE business and the exit from the private label diaper operations in the United States are expected to negatively impact sales by about 240 bps.Adjusted operating profit is now expected to be flat to positive on a constant-currency basis compared with the previous expectation of high single-digit growth. This outlook continues to include a 320-bps negative impact from the PPE divestiture and the exit from the private label diaper business. Operating profit growth will also face a negative impact of approximately 200 bps from unfavorable currency rates compared with the previous forecast of 300 bps.Adjusted earnings per share (EPS) are now expected to be flat to positive on a constant-currency basis, including a 320-bps adverse impact from the divestitures and a 100-bps negative impact from factors below operating profit, such as higher net interest expense, a higher effective tax rate and fewer shares outstanding. In addition, EPS is also expected to be negatively impacted by around 300 bps from currency translation, including the impact on income from equity interests compared with a previously estimated 350-400 basis points.KMB stock has gained 10.3% in the past three months compared with the industry’s growth of 2%.Image Source: Zacks Investment ResearchOther Stocks to ConsiderUnited Natural Foods, Inc. UNFI distributes natural, organic, specialty, produce and conventional grocery and non-food products in the United States and Canada. At present, United Natural carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The consensus estimate for United Natural’s current fiscal-year sales and earnings implies growth of 1.9% and 485.7%, respectively, from the year-ago figures. UNFI delivered a trailing four-quarter earnings surprise of 408.7%, on average.Utz Brands UTZ engages in the manufacture, marketing and distribution of snack foods in the United States and presently carries a Zacks Rank of 2. UTZ delivered a trailing four-quarter earnings surprise of 8.8%, on average.The Zacks Consensus Estimate for Utz Brands’ current financial-year sales and earnings indicates growth of 1.2% and 10.4%, respectively, from the year-ago numbers.BJ's Wholesale Club Holdings, Inc. BJ operates membership warehouse clubs on the eastern half of the United States and currently holds a Zacks Rank #2. BJ delivered an earnings surprise of 12% in the trailing four quarters, on average. The Zacks Consensus Estimate for BJ's Wholesale Club’s current fiscal-year sales and earnings implies growth of 5.8% and 4.4%, respectively, from the year-ago figures.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kimberly-Clark Corporation (KMB): Free Stock Analysis Report BJ's Wholesale Club Holdings, Inc. (BJ): Free Stock Analysis Report United Natural Foods, Inc. (UNFI): Free Stock Analysis Report Utz Brands, Inc. (UTZ): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Omnicom Group und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Omnicom Group
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Omnicom Group
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Omnicom Group Inc.
Analysen zu Omnicom Group Inc.
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Omnicom Group Market Perform | BMO Capital Markets | |
17.04.2019 | Omnicom Group Equal Weight | Barclays Capital | |
16.10.2018 | Omnicom Group Hold | Pivotal Research Group | |
03.04.2018 | Omnicom Group Hold | Pivotal Research Group | |
16.02.2018 | Omnicom Group Outperform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Omnicom Group Market Perform | BMO Capital Markets | |
16.02.2018 | Omnicom Group Outperform | BMO Capital Markets | |
18.10.2017 | Omnicom Group Outperform | RBC Capital Markets | |
18.10.2017 | Omnicom Group Outperform | Telsey Advisory Group | |
08.03.2017 | Omnicom Group Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
17.04.2019 | Omnicom Group Equal Weight | Barclays Capital | |
16.10.2018 | Omnicom Group Hold | Pivotal Research Group | |
03.04.2018 | Omnicom Group Hold | Pivotal Research Group | |
16.02.2018 | Omnicom Group Sector Perform | RBC Capital Markets | |
15.02.2018 | Omnicom Group Hold | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
13.04.2015 | Omnicom Group Sell | Pivotal Research Group | |
08.11.2007 | Omnicom Group sell | Banc of America Sec. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Omnicom Group Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen